Skip to content
  • YouTube
  • Facebook
  • LinkedIn
Pharm'Up

Pharm'Up

An E-platform for Learners

Primary Menu
  • Home
  • News
  • Industries
  • Disease
  • Drugs
  • Events
  • Jobs
  • Trainings
  • Conferences
  • Syllabus
  • Previous Papers
  • Notes
  • Colleges
Live
  • Home
  • 2025
  • July
  • 28
  • Common Sugar Substitute Tied to Brain Cell Harm and Higher Stroke Risk
  • Pharma News

Common Sugar Substitute Tied to Brain Cell Harm and Higher Stroke Risk

Pharm'Up 2 min read

Recent research from the University of Colorado Boulder has raised alarms about erythritol, a prevalent sweetener found in low-carb desserts, keto snacks, and “sugar-free” drinks. The study suggests this widely used sugar substitute and food additive may damage brain cells and increase the likelihood of stroke.

Christopher DeSouza, a professor of integrative physiology and head of the Integrative Vascular Biology Lab, who led the study, noted, “This research contributes to the mounting evidence that non-nutritive sweeteners, often deemed safe, might pose hidden health threats.”

Approved by the Food and Drug Administration in 2001, erythritol is a sugar alcohol made through corn fermentation. With virtually no calories, about 80% of table sugar’s sweetness, and little impact on insulin, it has become a go-to option for those managing weight, blood sugar, or cutting carbs.

Yet, emerging studies are highlighting potential hazards. A Cleveland Clinic investigation with 4,000 participants from the U.S. and Europe found that elevated erythritol levels in the bloodstream were strongly associated with a higher risk of heart attacks or strokes over the next three years.

To investigate further, DeSouza and lead researcher Auburn Berry, a graduate student in his team, exposed human brain blood vessel cells to erythritol levels typical of a sugar-free beverage for three hours. Their findings revealed:

  • A significant drop in nitric oxide, which helps expand and relax blood vessels.
  • An uptick in endothelin-1, a protein that tightens blood vessels.
  • A reduced ability to produce t-PA, a natural clot-dissolving agent, when exposed to thrombin.
  • Increased reactive oxygen species (ROS), or free radicals, which can harm cells and trigger inflammation.

Earlier studies have also shown that just 30g of erythritol—equivalent to a pint of sugar-free ice cream—can cause blood platelets to aggregate, raising the risk of clot formation.

Berry commented, “In essence, narrower blood vessels and diminished clot breakdown capacity heighten stroke risk. Our work not only supports this connection but also explores how erythritol might play a role.”

DeSouza pointed out that their experiment involved just one serving of erythritol, implying that multiple daily servings could worsen the effects. As this was a lab-based cell study, they urge larger human trials to validate the results.

They recommend that consumers scan labels for erythritol or “sugar alcohol” and consider limiting intake. DeSouza added, “Given the epidemiological insights that sparked our study and our cell-based discoveries, it’s prudent for people to be mindful of their consumption of non-nutritive sweeteners like erythritol.”

About the Author

Pharm'Up

Author

An E-platform for Pharma Learners

View All Posts

Post navigation

Previous: BP202T. PHARMACEUTICAL ORGANIC CHEMISTRY –I (Theory)
Next: Diploma in Pharmacy Colleges in Lucknow (U.P.)

Related Stories

Pharmup 4
2 min read
  • Pharma News

Future-Proofing Pharmacy: Saveetha College Webinar Explores the AI and IT Revolution

Pharm'Up
Pharmup 3
2 min read
  • Pharma News

Global Power Move: Sun Pharma’s $11.75 Billion Acquisition of Organon

Pharm'Up
Pharmup 2
2 min read
  • Pharma News

The Science of the “Super-Brush”: How Graphene Kills Bacteria Without Harming Humans

Pharm'Up

Recent Posts

  • Navigating Balance Disorders: Causes, Symptoms, and Management
  • Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief
  • Pharmacovigilance Specialist Opportunity at Bausch + Lomb
  • Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare
  • Sun Pharma Recruitment: Manager – EU Compliance (Tandalja R&D)

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025

Categories

  • Colleges
  • Conferences/ Workshops
  • Disease
  • Drugs
  • Events
  • Industries
  • Notes
  • Pharma Jobs
  • Pharma News
  • Previous Papers
  • Syllabus
  • Trainings/ Courses
  • Uncategorized

Read These Too

Pharmup 21
2 min read
  • Disease

Navigating Balance Disorders: Causes, Symptoms, and Management

Pharm'Up
Pharmup 20
1 min read
  • Disease

Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief

Pharm'Up
Pharmup 19
1 min read
  • Pharma Jobs

Pharmacovigilance Specialist Opportunity at Bausch + Lomb

Pharm'Up
Pharmup 18
1 min read
  • Pharma Jobs

Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare

Pharm'Up
  • YouTube
  • Facebook
  • LinkedIn
Copyright ©Pharm'UP All rights reserved by Eduversity India | MoreNews by AF themes.